Impact of Glucocorticoids upon Lipogenesis and beta-Oxidation in Skeletal Muscle.

Impact of Glucocorticoids upon Lipogenesis and beta-Oxidation in Skeletal Muscle.

Dettagli Bibliografici
Autori principali:	Morgan, SA, Gathercole, L, Bujalska, I, Stewart, P, Tomlinson, J
Natura:	Conference item
Pubblicazione:	2010

Documenti analoghi

Glucocorticoid and Insulin Regulation of Lipogenesis in Human Adipose Tissue.
di: Gathercole, L, et al.
Pubblicazione: (2010)

Glucocorticoid and insulin regulation of lipogenesis in human adipose tissue
di: Gathercole, L, et al.
Pubblicazione: (2010)

Regulation of lipogenesis by glucocorticoids and insulin in human adipose tissue
di: Gathercole, L, et al.
Pubblicazione: (2011)

11beta-hydroxysteroid dehydrogenase type 1 regulates glucocorticoid-induced insulin resistance in skeletal muscle.
di: Morgan, SA, et al.
Pubblicazione: (2009)

Regulation of lipid metabolism by glucocorticoids and 11β-HSD1 in skeletal muscle.
di: Morgan, SA, et al.
Pubblicazione: (2013)

Hormonal regulation of lipogenesis.
di: Gathercole, L, et al.
Pubblicazione: (2013)

Short- and long-term glucocorticoid treatment enhances insulin signalling in human subcutaneous adipose tissue.
di: Gathercole, L, et al.
Pubblicazione: (2011)

Glucocorticoid modulation of insulin signaling in human subcutaneous adipose tissue.
di: Gathercole, L, et al.
Pubblicazione: (2007)

11β-HSD1 is the major regulator of the tissue-specific effects of circulating glucocorticoid excess.
di: Morgan, SA, et al.
Pubblicazione: (2014)

Expression profiling of 11beta-hydroxysteroid dehydrogenase type-1 and glucocorticoid-target genes in subcutaneous and omental human preadipocytes.
di: Bujalska, I, et al.
Pubblicazione: (2006)

11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response.
di: Tomlinson, J, et al.
Pubblicazione: (2004)

A novel selective 11beta-hydroxysteroid dehydrogenase type 1 inhibitor prevents human adipogenesis.
di: Bujalska, I, et al.
Pubblicazione: (2008)

Hexose-6-phosphate dehydrogenase confers oxo-reductase activity upon 11 beta-hydroxysteroid dehydrogenase type 1.
di: Bujalska, I, et al.
Pubblicazione: (2005)

The role of 11 beta-hydroxysteroid dehydrogenase in central obesity and osteoporosis.
di: Tomlinson, J, et al.
Pubblicazione: (2000)

The role of 11beta-hydroxysteroid dehydrogenase 1 in adipogenesis in thyroid-associated ophthalmopathy.
di: Tomlinson, J, et al.
Pubblicazione: (2010)

5α-reductase type 2 regulates glucocorticoid action and metabolic phenotype in human hepatocytes
di: Nasiri, M, et al.
Pubblicazione: (2015)

Neonatal overfeeding induced glucocorticoid overexposure accelerates hepatic lipogenesis in male rats
di: Fan Yang, et al.
Pubblicazione: (2018-05-01)

Muscle atrophy in response to cytotoxic chemotherapy is dependent on intact glucocorticoid signaling in skeletal muscle.
di: Theodore P Braun, et al.
Pubblicazione: (2014-01-01)

Expression of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue is not increased in human obesity.
di: Tomlinson, J, et al.
Pubblicazione: (2002)

11Beta-hydroxysteroid dehydrogenase type 1 in differentiating omental human preadipocytes: from de-activation to generation of cortisol.
di: Bujalska, I, et al.
Pubblicazione: (2002)

Sexual Dimorphism in Transcriptional and Functional Glucocorticoid Effects on Mouse Skeletal Muscle
di: Sheng Li, et al.
Pubblicazione: (2022-07-01)

Glucocorticoids fail to cause insulin resistance in human subcutaneous adipose tissue in vivo.
di: Hazlehurst, J, et al.
Pubblicazione: (2013)

Impact of Oxidative Stress on Exercising Skeletal Muscle
di: Peter Steinbacher, et al.
Pubblicazione: (2015-04-01)

The Expression of Can and Camk is Associated with Lipogenesis in the Muscle of Chicken
di: Y Yang, et al.
Pubblicazione: (2015-09-01)

Dehydroepiandrosterone exerts antiglucocorticoid action on human preadipocyte proliferation, differentiation, and glucose uptake.
di: McNelis, J, et al.
Pubblicazione: (2013)

Modulation of glucocorticoid action and the treatment of type-2 diabetes.
di: Tomlinson, J, et al.
Pubblicazione: (2007)

Androgen generation in adipose tissue in women with simple obesity--a site-specific role for 17beta-hydroxysteroid dehydrogenase type 5.
di: Quinkler, M, et al.
Pubblicazione: (2004)

Intermittent glucocorticoid treatment enhances skeletal muscle performance through sexually dimorphic mechanisms
di: Isabella M. Salamone, et al.
Pubblicazione: (2022-03-01)

IRES-mediated translation of utrophin A is enhanced by glucocorticoid treatment in skeletal muscle cells.
di: Pedro Miura, et al.
Pubblicazione: (2008-01-01)

AKR1D1 regulates glucocorticoid availability and glucocorticoid receptor activation in human hepatoma cells.
di: Nikolaou, N, et al.
Pubblicazione: (2019)

Alterations of Lysine Acetylation Profile in Murine Skeletal Muscles Upon Exercise
di: Dehuan Liang, et al.
Pubblicazione: (2022-05-01)

Activation of skeletal muscle–resident glial cells upon nerve injury
di: Daisy Proietti, et al.
Pubblicazione: (2021-04-01)

Mineralocorticoid receptor antagonists and glucocorticoids differentially affect skeletal muscle inflammation and pathology in muscular dystrophy
di: Zachary M. Howard, et al.
Pubblicazione: (2022-10-01)

Acute intermittent hypoxia drives hepatic de novo lipogenesis in humans and rodents
di: Hazlehurst, JM, et al.
Pubblicazione: (2022)

Oxidative Stress in Skeletal Muscle
di: Giorgio Fanò-Illic, et al.
Pubblicazione: (2022-06-01)

Women have higher protein content of beta-oxidation enzymes in skeletal muscle than men.
di: Amy C Maher, et al.
Pubblicazione: (2010-08-01)

Pomegranate peel as a phytogenic in broiler chickens: Influence upon antioxidant, lipogenesis and hypotensive response
di: Behnam Ahmadipour, et al.
Pubblicazione: (2021-09-01)

Skeletal muscle 11beta-HSD1 controls glucocorticoid-induced proteolysis and expression of E3 ubiquitin ligases atrogin-1 and MuRF-1.
di: Katrin Biedasek, et al.
Pubblicazione: (2011-01-01)

Antagonizing urotensin receptor is a novel therapeutic strategy for glucocorticoid‐induced skeletal muscle atrophy
di: Lin Yin, et al.
Pubblicazione: (2022-05-01)

Effects of glucocorticoids on fat mass and the therapeutic potential of targeting II beta-hydroxysteroid dehydrogenase type I in obesity
di: Tomlinson, J
Pubblicazione: (2009)